Functions And Performance of Orion Pharma Limited Bangladesh

Orion

Group
"Times New Roman""> is one of the leading industrial conglomerates in

Bangladesh which started business in the Pharmaceutical Sector. Orion Pharma Limited, a Company of

Orion Group, owns and operates a modern pharmaceutical factory and produces and

markets pharmaceutical drugs and medicines. The company was incorporated as a Private Limited Company

on June 21, 1965 and converted into a Public Limited Company on June 24, 2010

under the Companies Act, 1994.
mso-fareast-font-family:"Times New Roman"">The company is a listed company with

Dhaka Stock Exchange (DSE) and Chittagong Stock Exchange (CSE) since 2013.

mso-fareast-font-family:"Times New Roman"">Orion Group is endowed with a highly

diversified portfolio of Pharma & Healthcare, Power Generation &

Energy, Shipping, Infrastructure Development, Real Estate & Construction,

Cosmetics & Toiletries, High-tech Agro Products, Food & Restaurant

Chain, Textiles & Garments and Home Appliance sectors. It is an honor for

me to be working in such a renowned Group and as majority of my work involves

with working and analyzing the operations and performance of Orion Pharma

Limited, I have decided to present my Internship

Topic upon Orion Pharma Limited.

mso-fareast-font-family:"Times New Roman"">Orion Pharma Limited (OPL) is

committed to deliver top quality essential general drugs, with long proven

reliabilities to the medical science community, healthcare professionals,

chemists and patients through 121 brands and 230 presentations of various

formulations complying Good Manufacturing Practices (GMP) and the guidelines of

ISO-9001:2008.

OPL’s

distribution network connects patients with healthcare products across urban

and rural area. The company distributes its products all over the country using

its own distribution channel. It has a large number of vehicles and sales depots

to ensure coverage of the whole country. OPL is committed to ensure better life

through quality medicines. Under the direct surveillance of the Central

Distribution Cell, 685 people ensure the on-time delivery through 19 depots and

45 customized vehicles confer the quality till it reaches to the hand

offend-customers.

OPL steps

forward in the overseas pharmaceutical market with peak precedence long ago. As

of now the company has overseas marketing network in Myanmar, Nepal, Armenia,

Sri Lanka, Lesotho, Cambodia, Afghanistan and Somalia. Some products of OPL

have already been registered in Egypt, Philippines, Sudan, Uganda and Yemen.

mso-fareast-font-family:"Times New Roman"">The company has its head office in

Tejgaon, Dhaka, Bangladesh. There are several departments in the head office -

Corporate Affairs, Company Affairs, Operations, Supply Chain Management,

Product Management Development, Finance, Accounts, Export, Commercial,

Marketing and Human Resource & Administration. At present, I am working in

the Company Affairs Department where

the overall business

is followed up.

mso-fareast-font-family:"Times New Roman"">Orion Pharma believes that the fair

practice of excellent corporate governance is fundamental to ensuring the

success of the company.  The Board of

Directors of Orion Pharma Limited is responsible for the Corporate Governance

of the company. Orion Pharma Limited has two subsidiaries namely Orion Power

Meghnaghat Limited and Dutch Bangla Power & Associates Limited. The company

also has an associate called Orion Infusion Limited. The company holds

regularly the Annual General Meeting as per law. Quarterly, Half-yearly and the

Annual financial statements are also posted at company’s website to keep all

the stakeholders informed about the Company’s financial results.

mso-fareast-font-family:"Times New Roman"">The year wise financial performance

shows that the consolidated sales revenue of the company rose from BDT 7,026.33

million from the year 2011 to BDT 14,799.74 million in the year ending June 2016.

The consolidated net profit of the company rose from BDT 862.97 million from

the year 2011 to BDT 1,323.07 million in the year ending June 2016. The growth

of the company is now in a steady position.

mso-fareast-font-family:"Times New Roman"">The financial performance of the

company is measured based on the data from the consolidated financial

statements from the year 2011 to June 2016. The current ratio of the company

was only 0.85 in the year 2011. Since then, it increased and it was 2.15 in the

year 2016. The EBITDA of the company was BDT 2,123.18 million in the year 2011

and it became BDT 3,763.93 million in the year 2016. The company is maintaining

a low risk in case of financing since the beginning. The debt to equity ratio

was 0.64 in the year 2016 which was .84 in the year 2011. From 2011 to 2016 the

company’s financial performance was slightly unfavorable due to political

instability, discontinued power supply and also the stock market crash

immediately after the company has its IPO in 2010. However, the company is

trying to enhance its performance and has already started to overcome various

barriers in the way of its success.

mso-fareast-font-family:"Times New Roman"">Orion Pharma Limited has been quite

conscious of its responsibility and tries to be fully compliant with all

Government regulations. During 2016 the company contributed BDT 499.78 million

to the Government Treasury in the form of VAT, Tax, Import Duty, Supplementary

Duty and this contribution represents 20.40% of net sales revenue. This is a

regular yearly phenomenon and every year the company contributes a significant amount

to the National exchequer in the form of Import Duty, Import VAT, Import Tax, Supplementary

Duty and Other Duties and Taxes.